| International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ... The lancet oncology 15 (12), e538-e548, 2014 | 4960 | 2014 |
| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2475 | 2016 |
| Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, ... Blood, The Journal of the American Society of Hematology 113 (22), 5412-5417, 2009 | 1382 | 2009 |
| Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and … RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ... Leukemia 24 (6), 1121-1127, 2010 | 1015 | 2010 |
| Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015 | 766 | 2015 |
| Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients C Blimark, E Holmberg, UH Mellqvist, O Landgren, M Björkholm, ... haematologica 100 (1), 107, 2015 | 513 | 2015 |
| Solid cancers after allogeneic hematopoietic cell transplantation JD Rizzo, RE Curtis, G Socié, KA Sobocinski, E Gilbert, O Landgren, ... Blood, The Journal of the American Society of Hematology 113 (5), 1175-1183, 2009 | 498 | 2009 |
| Racial disparities in incidence and outcome in multiple myeloma: a population-based study AJ Waxman, PJ Mink, SS Devesa, WF Anderson, BM Weiss, ... Blood, The Journal of the American Society of Hematology 116 (25), 5501-5506, 2010 | 449 | 2010 |
| Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation O Landgren, ES Gilbert, JD Rizzo, G Socié, PM Banks, KA Sobocinski, ... Blood, The Journal of the American Society of Hematology 113 (20), 4992-5001, 2009 | 438 | 2009 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 435 | 2016 |
| B-cell clones as early markers for chronic lymphocytic leukemia O Landgren, M Albitar, W Ma, F Abbasi, RB Hayes, P Ghia, GE Marti, ... New England Journal of Medicine 360 (7), 659-667, 2009 | 428 | 2009 |
| Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group C Fernández de Larrea, RA Kyle, BGM Durie, H Ludwig, S Usmani, ... Leukemia 27 (4), 780-791, 2013 | 410 | 2013 |
| Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus TP Giordano, L Henderson, O Landgren, EY Chiao, JR Kramer, ... Jama 297 (18), 2010-2017, 2007 | 410 | 2007 |
| Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003 SY Kristinsson, O Landgren, PW Dickman, AR Derolf, M Bjorkholm Journal of clinical oncology 25 (15), 1993-1999, 2007 | 399 | 2007 |
| Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States O Landgren, G Gridley, I Turesson, NE Caporaso, LR Goldin, D Baris, ... Blood 107 (3), 904-906, 2006 | 379 | 2006 |
| Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised … M Dimopoulos, H Quach, MV Mateos, O Landgren, X Leleu, D Siegel, ... The Lancet 396 (10245), 186-197, 2020 | 372 | 2020 |
| Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population‐based study of US veterans HB El‐Serag, EA Engels, O Landgren, E Chiao, L Henderson, ... Hepatology 49 (1), 116-123, 2009 | 342 | 2009 |
| Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004 GM Dores, O Landgren, KA McGlynn, RE Curtis, MS Linet, SS Devesa British journal of haematology 144 (1), 86-94, 2009 | 340 | 2009 |
| Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up SY Kristinsson, G Gridley, RN Hoover, D Check, O Landgren haematologica 99 (2), 392, 2014 | 334 | 2014 |
| Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology GM Dores, WF Anderson, RE Curtis, O Landgren, E Ostroumova, ... British journal of haematology 139 (5), 809-819, 2007 | 332 | 2007 |
